Pharmacology of nicotinic receptors in preBötzinger complex that mediate modulation of respiratory pattern

Journal of Neurophysiology

Volumn 88, Issue 4, 2002, Pages 1851-1858

  Shao, Xuesi M ^a   Feldman, Jack L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; DIHYDRO BETA ERYTHROIDINE; HEXAMETHONIUM; METHYLLYCACONITINE; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; TUBOCURARINE CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; BREATHING PATTERN; BREATHING RATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HYPOGLOSSAL NERVE; NEUROMODULATION; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PATCH CLAMP; PREBOTZINGER COMPLEX; PRIORITY JOURNAL; RAT; RESPIRATION CENTER; VOLTAGE CLAMP;

EID: 0036798596     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2002.88.4.1851     Document Type: Article

References (53)

1. Bencherif M, Lovette ME, Fowler KW, Arrington S, Reeves L, Caldwell WS, and Lippiello PM. RJR-2403: a nicotinic agonist with CNS selectivity. I. In vitro characterization. J Pharmacol Exp Ther 279: 1413-1421, 1996.
2. Böhmer G, Schmid K, and Baumann M. Evidence for a respiration-modulated cholinergic action on the activity of medullary respiration-related neurons in the rabbit. An iontophoretic study. Pflügers Arch 415: 72-80, 1989.
3. Böhmer G, Schmid K, Schmidt P, and Stehle J. Cholinergic effects on spike density and burst duration of medullary respiration-related neurons in the rabbit: an iontophoretic study. Neuropharmacology 26: 1561-1572, 1987.
4. Bradley PB and Lucy AP. Cholinoceptive properties of respiratory neurons in the rat medulla. Neuropharmacology 22: 853-858, 1983.
5. Burton MD, Nouri K, Baichoo S, Samuels-Toyloy N, and Kazemi H. Ventilatory output and acetylcholine: perturbations in release and muscarinic receptor activation. J Appl Physiol 77: 2275-2284, 1994.
6. Butera R, Rinzel J, and Smith J. Models of respiratory rhythm generation in the pre-Bötzinger complex. II. Populations of coupled pacemaker neurons. J Neurophysiol 82: 398-451, 1999.
7. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, and Johnson EC. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4, and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280: 346-356, 1997.
8. Clementi F, Fornasari D, and Gotti C. Neuronal nicotinic receptors, important new players in brain function. Eur J Pharmacol 393: 3-10, 2000.
9. Colquhoun LM and Patrick JW. Alpha3, beta2, and beta4 form heterotrimeric neuronal nicotinic acetylcholine receptors in Xenopus oocytes. J Neurochem 69: 2355-2362, 1997.
10. Dominguez Del Toro E, Juiz JM, Peng X, Lindstrom J, and Criado M. Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol 349: 325-342, 1994.
11. Gesell R, Hansen E, and Worzniak J. Humoral intermediation of nerve cell activation in the central nervous system. Am J Physiol 138: 776-791, 1943.
12. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattonikaplan M, Donnelly-Roberts D, Arneric SP, and Sullivan JP. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J Pharmacol Exp Ther 276: 289-297, 1996.
13. Gothe B, Strohl KP, Levin S, and Cherniack NS. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 87: 11-17, 1985.
14. Gray PA, Rekling JC, Bocchiaro CM, and Feldman JL. Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the preBötzinger complex. Science 286: 1566-1568, 1999.
15. Haji A, Furuichi S, and Takeda R. Effects on iontophoretically applied acetylcholine on membrane potential and synaptic activity of bulbar respiratory neurones in decerebrate cats. Neuropharmacology 35: 195-203, 1996.
16. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, and London ED. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 33: 23-29, 1993.
17. Howell LL. Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys. J Pharmacol Exp Ther 273: 1085-1094, 1995.
18. Jones S, Sudweeks S, and Yakel JL. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 22: 555-561, 1999.
19. Jordan D and Spyer KM. Effects of acetylcholine on respiratory neurons in the nucleus ambiguus-retroambigualis complex of the cat. J Physiol (Lond) 320: 103-111, 1981.
20. Kirsten EB, Satayavivad J, St John WM, and Wang SC. Alteration of medullary respiratory unit discharge by iontophoretic application of putative neurotransmitters. Br J Pharmacol 63: 275-281, 1978.
21. Klink R, De Kerchove D'Exaerde A, Zoli M, and Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the mid-brain dopaminergic nuclei. J Neurosci 21: 1452-1463, 2001.
22. Klonoff-Cohen HS, Edelstein SL, Lefkowitz ES, Srinivasan IP, Kaegi D, Chang JC, and Wiley KJ. The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. J Am Med Ass 273: 795-798, 1995.
23. Le Novere N, Zoli M, Lena C, Ferrari R, Picciotto MR, Merlo-Pich E, and Changeux JP. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion demonstrated by in vivo antisense oligonucleotide infusion. Neuroreport 10: 2497-2501, 1999.
24. Levin ED, Bettegowda C, Blosser J, and Gordon J. AR-R17779, an alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10: 675-680, 1999.
25. Lippiello PM, Bencherif M, Gray JA, Peters S, Grigoryan G, Hodges H, and Collins AC. RJR-2403: a nicotinic agonist with CNS selectivity. II. In vivo characterization. J Pharmacol Exp Ther 279: 1422-1429, 1996.
26. Lipton SA, Aizenman E, and Lorino RH. Neural nicotinic acetylcholine responses in solitary mammalian retinal ganglion cells. Pflügers Arch 410: 37-43, 1987.
27. Lotti M. Treatment of acute organophosphate poisoning. Med J Aust 154: 51-55, 1991.
28. Luetje CW and Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11: 837-845, 1991.
29. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, and Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51: 397-401, 1999.
30. Lustig LR, Peng H, Hiel H, Yamamoto T, and Fuchs PA. Molecular cloning and mapping of the human nicotinic acetylcholine receptor alphal0 (CHRNA10). Genomics 73: 272-283, 2001.
31. McGehee DS and Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57: 521-546, 1995.
32. Murakoshi T, Suzue T, and Tamai S. A pharmacological study on respiratory rhythm in the isolated brain stem-spinal cord preparation of the newborn rat. Br J Pharmacol 86: 95-104, 1985.
33. Neff RA, Humphrey J, Mihalevich M, and Mendelowitz D. Nicotine enhances presynaptic and postsynaptic glutamatergic neurotransmission to activate cardiac parasympathetic neurons. Circ Res 83: 1241-1247, 1998.
34. Neter J, Wasserman W, and Kutner MH. Repeated measures and related designs. In: Applied Linear Statistical Models (3rd ed.). Homewood, IL: Richard D Irwin, 1990, p. 1035-1073.
35. Nomikos GG, Schilstrom B, Hildebrand BE, Panagis G, Grenhoff J, and Svensson TH. Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav Brain Res 113: 97-103, 2000.
36. Papke RL, Webster JC, Lippiello PM, Bencherif M, and Francis MM. The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype. J Neurochem 75: 204-216, 2000.
37. Picciotto MR, Caldarone BJ, King SL, and Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22: 451-465, 2000.
38. Rezvani AH and Levin ED. Cognitive effects of nicotine. Biol Psychiatry 49: 258-267, 2001.
39. Rickett DL, Glenn JF, and Beers ET. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 7: 225-236, 1986.
40. Robinson DM, Peebles KC, Kwok H, Adams BM, Clarke LL, Woollard GA, and Funk GD. Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice. J Physiol (Lond) 538: 957-973, 2002.
41. Rusted JM, Newhouse PA, and Levin ED. Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. Behav Brain Res 113: 121-129, 2000.
42. Salmoiraghi GC and Steiner FA. Acetylcholine sensitivity of Cat's medullary neurons. J Neurophysiol 26: 581-597, 1963.
43. SAS INSTITUTE INC. The MIXED procedure. In: SAS/STAT User's Guide (8 ed.), Cary, NC: SAS Institute, 1999, p. 2083-2226.
44. Shao XM and Feldman JL. Mechanisms underlying regulation of respiratory pattern by nicotine in preBötzinger Complex. J Neurophysiol 85: 2461-2467, 2001.
45. Smith JC, Ellenberger HH, Ballanyi K, Richter DW, and Feldman JL. Pre-Bötzinger complex: a brain stem region that may generate respiratory rhythm in mammals. Science 254: 716-719, 1991.
46. Stepans MBF and Wilkerson N. Physiologic effects of maternal smoking on breast-feeding infants. J Am Acad Nurse Practitioners 5: 105-113, 1998.
47. Taylor JA and Sanderson M. A reexamination of the risk factors for the sudden infant death syndrome. J Pediatr 126: 887-891, 1995.
48. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, and Swanson LW. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284: 314-335, 1989.
49. Wang J, Irnaten M, Neff RA, Venkatesan P, Evans C, Loewy AD, Mettenleiter TC, and Mendelowitz D. Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus. Ann NY Acad Sci 940: 237-246, 2001.
50. Weinstock M, Roll D, and Zilberman Y. An analysis of the respiratory stimulant effect of physostigmine and neostigmine in the conscious rabbit. Clin Exp Pharmacol Physiol 8: 151-158, 1981.
51. Wetter DW, Young TB, Bidwell TR, Badr MS, and Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 154: 2219-2224, 1994.
52. Whiting P, Schoepfer R, Lindstrom J, and Priestley T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol 40: 463-472, 1991.
53. Zoli M, Lena C, Picciotto MR, and Changeux JP. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 18: 4461-4472, 1998.